AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism
Oncology Research · 2026 · 34 (1) · 1-10
DOI: 10.32604/or.2025.070558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Shenghui Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: JXHC Key Laboratory of Digital Orthopaedics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchan…. Hauptthemen laut MEDLINE: Osteosarcoma, Lysophospholipids, Tumor Microenvironment, Bone Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- JXHC Key Laboratory of Digital Orthopaedics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, China.
Zitieren
APA
Su, S., Zeng, Y., Chen, J., & Dong, X. (2026). AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism. Oncology Research, 34(1), 1-10. https://doi.org/10.32604/or.2025.070558
Vancouver
Su S, Zeng Y, Chen J, Dong X. AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism. Oncology Research. 2026;34(1):1-10. doi:10.32604/or.2025.070558
BibTeX
@article{Su2026,
author = {Su, Shenghui and Zeng, Yu and Chen, Jiaxin and Dong, Xieping},
title = {AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism},
journal = {Oncology Research},
year = {2026},
volume = {34},
number = {1},
pages = {1--10},
doi = {10.32604/or.2025.070558}
}
EUVIMED